StayWell Guam Inc.

Drug Recall: Sulfate Tablets

StayWell Insurance | July 30, 2025 | Maite, GU

If you have received a prescription for Sucralfate Tablets USP 1 gram, please be aware that your medication may be impacted by a recent recall. All lots of Sucralfate Tablets USP 1 gram are being recalled as a result of the manufacturer, Nostrum Laboratories, closure and discontinuation of its quality activities. Nostrum Labs distributed the product at issue here to wholesalers, retailers, manufacturers, medical facilities, and repackagers. It cannot be guaranteed that any lots of this product that are still within expiry will meet all intended specifications through the labeled shelf life of the product. Further distribution or use of any remaining product on the market should cease immediately.

The U.S. Food and Drug Administration (FDA) announcedas the following, effective immediately:

• Consumers with questions regarding this recall can be directed to Nostrum Labs at [email protected]. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product

• Patients are encouraged to report adverse events or side effects related to the use of this product to FDA's MedWatch Safety Information and Adverse Event Reporting Program at 1-800-332-1088 or online at www.fda.gov/MedWatch/report.htm.

Additional information is available at: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts.

Please disregard this letter if you are not currently taking Sucralfate Tablets USP 1 gram or if this safety warning does not apply to you. Our records may not be complete, or your doctor may have discontinued this medication.

• MedImpact - Nostrum Labs Member Letter